Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Goodwill (2016 - 2021)

Historic Goodwill for Abeona Therapeutics (ABEO) over the last 7 years, with Q3 2021 value amounting to $32.5 million.

  • Abeona Therapeutics' Goodwill changed 0.0% to $32.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $32.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $32.5 million for FY2020, which is N/A changed from last year.
  • Abeona Therapeutics' Goodwill amounted to $32.5 million in Q3 2021, which was down 0.0% from $32.5 million recorded in Q2 2021.
  • Abeona Therapeutics' 5-year Goodwill high stood at $32.5 million for Q4 2020, and its period low was $32.5 million during Q1 2017.
  • In the last 5 years, Abeona Therapeutics' Goodwill had a median value of $32.5 million in 2017 and averaged $32.5 million.
  • Within the past 5 years, the most significant YoY rise in Abeona Therapeutics' Goodwill was 0.0% (2017), while the steepest drop was 0.0% (2017).
  • Abeona Therapeutics' Goodwill (Quarter) stood at $32.5 million in 2017, then changed by 0.0% to $32.5 million in 2018, then changed by 0.0% to $32.5 million in 2019, then grew by 0.1% to $32.5 million in 2020, then dropped by 0.1% to $32.5 million in 2021.
  • Its Goodwill stands at $32.5 million for Q3 2021, versus $32.5 million for Q2 2021 and $32.5 million for Q1 2021.